Matches in SemOpenAlex for { <https://semopenalex.org/work/W2416728558> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W2416728558 endingPage "26" @default.
- W2416728558 startingPage "16" @default.
- W2416728558 abstract "Statins, widely used cholesterol-lowering agents, have also been demonstrated to have anti-inflammatory and immunomdulatory effects.To evaluate the effects of atorvastatin in combination with Interferon-β in the treatment of multiple sclerosis (MS) in a randomized controlled clinical trial.Multiple sclerosis patients were randomized independently, in a double blind design, into one of two treatment groups. Control group (n=45) received 30 μg/week interferon β-1a via intra-muscular injection. Atorvastatin-treated group (n=50) received interferon β-1a similar to control group in addition to atorvastatin (40 mg/day) for 18-months. All clinical and immunological variables were measured at the baseline and at the end of the study.There was no significant difference between the two groups in the expanded disability status scale scores and the number of gadolinium-enhancing lesions during the 18-month treatment period. After 18 months, the levels of interleukin (IL)-4, IL-10, transforming growth factor-β and serum ferric reducing antioxidant power in the atorvastatin treatment group were significantly higher than the control group. Levels of IL-17, TNF-α and lymphocyte proliferation in the atorvastatin treatment group were significantly lower than the control group.Although combined atorvastatin and interferon-β do not change the clinical course of MS, atorvastatin might have beneficial effects in MS treatment possibly through inducing anti-inflammatory responses." @default.
- W2416728558 created "2016-06-24" @default.
- W2416728558 creator A5005410851 @default.
- W2416728558 creator A5005733348 @default.
- W2416728558 creator A5010813911 @default.
- W2416728558 creator A5035920795 @default.
- W2416728558 creator A5059812307 @default.
- W2416728558 date "2016-03-01" @default.
- W2416728558 modified "2023-09-23" @default.
- W2416728558 title "Interferon β-1a and Atorvastatin in the Treatment of Multiple Sclerosis." @default.
- W2416728558 cites W1486185606 @default.
- W2416728558 cites W1558832373 @default.
- W2416728558 cites W1907316344 @default.
- W2416728558 cites W1965452646 @default.
- W2416728558 cites W1967957947 @default.
- W2416728558 cites W1977595948 @default.
- W2416728558 cites W1979952479 @default.
- W2416728558 cites W1980857453 @default.
- W2416728558 cites W1999627066 @default.
- W2416728558 cites W1999895981 @default.
- W2416728558 cites W2000672398 @default.
- W2416728558 cites W2012636039 @default.
- W2416728558 cites W2019061419 @default.
- W2416728558 cites W2028313592 @default.
- W2416728558 cites W2031329453 @default.
- W2416728558 cites W2040870583 @default.
- W2416728558 cites W2048875185 @default.
- W2416728558 cites W2053714231 @default.
- W2416728558 cites W2059209526 @default.
- W2416728558 cites W2059632051 @default.
- W2416728558 cites W2061238254 @default.
- W2416728558 cites W2063758367 @default.
- W2416728558 cites W2072718666 @default.
- W2416728558 cites W2074996264 @default.
- W2416728558 cites W2082899678 @default.
- W2416728558 cites W2090071786 @default.
- W2416728558 cites W2101344028 @default.
- W2416728558 cites W2122545833 @default.
- W2416728558 cites W2127549376 @default.
- W2416728558 cites W2147292685 @default.
- W2416728558 cites W2338977280 @default.
- W2416728558 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27026043" @default.
- W2416728558 hasPublicationYear "2016" @default.
- W2416728558 type Work @default.
- W2416728558 sameAs 2416728558 @default.
- W2416728558 citedByCount "2" @default.
- W2416728558 countsByYear W24167285582022 @default.
- W2416728558 countsByYear W24167285582023 @default.
- W2416728558 crossrefType "journal-article" @default.
- W2416728558 hasAuthorship W2416728558A5005410851 @default.
- W2416728558 hasAuthorship W2416728558A5005733348 @default.
- W2416728558 hasAuthorship W2416728558A5010813911 @default.
- W2416728558 hasAuthorship W2416728558A5035920795 @default.
- W2416728558 hasAuthorship W2416728558A5059812307 @default.
- W2416728558 hasConcept C126322002 @default.
- W2416728558 hasConcept C168563851 @default.
- W2416728558 hasConcept C203014093 @default.
- W2416728558 hasConcept C2777482532 @default.
- W2416728558 hasConcept C2780640218 @default.
- W2416728558 hasConcept C535046627 @default.
- W2416728558 hasConcept C71924100 @default.
- W2416728558 hasConcept C90924648 @default.
- W2416728558 hasConcept C98274493 @default.
- W2416728558 hasConceptScore W2416728558C126322002 @default.
- W2416728558 hasConceptScore W2416728558C168563851 @default.
- W2416728558 hasConceptScore W2416728558C203014093 @default.
- W2416728558 hasConceptScore W2416728558C2777482532 @default.
- W2416728558 hasConceptScore W2416728558C2780640218 @default.
- W2416728558 hasConceptScore W2416728558C535046627 @default.
- W2416728558 hasConceptScore W2416728558C71924100 @default.
- W2416728558 hasConceptScore W2416728558C90924648 @default.
- W2416728558 hasConceptScore W2416728558C98274493 @default.
- W2416728558 hasIssue "1" @default.
- W2416728558 hasLocation W24167285581 @default.
- W2416728558 hasOpenAccess W2416728558 @default.
- W2416728558 hasPrimaryLocation W24167285581 @default.
- W2416728558 hasRelatedWork W1977094709 @default.
- W2416728558 hasRelatedWork W2019135295 @default.
- W2416728558 hasRelatedWork W2160152341 @default.
- W2416728558 hasRelatedWork W2335494140 @default.
- W2416728558 hasRelatedWork W2353511282 @default.
- W2416728558 hasRelatedWork W2370766369 @default.
- W2416728558 hasRelatedWork W2380319386 @default.
- W2416728558 hasRelatedWork W2575457464 @default.
- W2416728558 hasRelatedWork W2899084033 @default.
- W2416728558 hasRelatedWork W2083697902 @default.
- W2416728558 hasVolume "13" @default.
- W2416728558 isParatext "false" @default.
- W2416728558 isRetracted "false" @default.
- W2416728558 magId "2416728558" @default.
- W2416728558 workType "article" @default.